These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27438337)

  • 1. New diagnostic criteria for neurocysticercosis: Reliability and validity.
    Carpio A; Fleury A; Romo ML; Abraham R; Fandiño J; Durán JC; Cárdenas G; Moncayo J; Leite Rodrigues C; San-Juan D; Serrano-Dueñas M; Takayanagui O; Sander JW
    Ann Neurol; 2016 Sep; 80(3):434-42. PubMed ID: 27438337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal contribution of clinical studies and the HP10 antigen ELISA for the diagnosis of extraparenchymal neurocysticercosis.
    Parkhouse RME; Carpio A; Campoverde A; Sastre P; Rojas G; Cortez MM
    Acta Trop; 2018 Feb; 178():119-123. PubMed ID: 29155204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and therapeutic difficulties in neurocysticercosis: presentation of 6 cases and review of the literature].
    Enseñat J; Martínez-Mañas R; Horcajada JP; De Juan C; Ferrer E
    Neurocirugia (Astur); 2007 Apr; 18(2):101-10. PubMed ID: 17497055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocysticercosis: Clinical Characteristics and Changes from 26 Years of Experience in an University Hospital in Korea.
    Son HJ; Kim MJ; Jung KH; Choi S; Jung J; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Jung BK; Song H; Chai JY
    Korean J Parasitol; 2019 Jun; 57(3):265-271. PubMed ID: 31284349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
    Kim SK; Wang KC; Paek SH; Hong KS; Cho BK
    Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-five years of evolution of standard diagnostic criteria for neurocysticercosis. How have they impacted diagnosis and patient outcomes?
    Del Brutto OH
    Expert Rev Neurother; 2020 Feb; 20(2):147-155. PubMed ID: 31855080
    [No Abstract]   [Full Text] [Related]  

  • 7. Reliability of Diagnostic Criteria for Neurocysticercosis for Patients with Ventricular Cystic Lesions or Granulomas: A systematic review.
    Bustos JA; García HH; Del Brutto OH
    Am J Trop Med Hyg; 2017 Sep; 97(3):653-657. PubMed ID: 28820689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of T24H-his, GST-T24H and GST-Ts8B2 recombinant antigens in western blot, ELISA and multiplex bead-based assay for diagnosis of neurocysticercosis.
    Hernández-González A; Noh J; Perteguer MJ; Gárate T; Handali S
    Parasit Vectors; 2017 May; 10(1):237. PubMed ID: 28506245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraparenchymal neurocysticercosis in Albuquerque, New Mexico.
    Figueroa JJ; Davis LE; Magalhaes A
    J Neuroimaging; 2011 Jan; 21(1):38-43. PubMed ID: 20002970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte transformation test: a new method for diagnosis of neurocysticercosis.
    Prasad A; Prasad KN; Yadav A; Gupta RK; Pradhan S; Jha S; Tripathi M; Husain M
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):198-202. PubMed ID: 18272315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraparenchymal neurocysticercosis in the United States.
    Kelesidis T; Tsiodras S
    Am J Med Sci; 2012 Jul; 344(1):79-82. PubMed ID: 22222333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of extraparenchymal neurocysticercosis.
    Murrieta I; Flores X; Osorio R; Kuschick Feher J; Carrillo-Mezo R; Fleury A
    Trans R Soc Trop Med Hyg; 2021 Oct; 115(10):1218-1225. PubMed ID: 33587139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the MTT lymphocyte proliferation assay for the diagnosis of neurocysticercosis.
    Verma A; Prasad KN; Singh AK; Nyati KK; Gupta RK; Paliwal VK
    J Microbiol Methods; 2010 May; 81(2):175-8. PubMed ID: 20211664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocysticercosis in the United States: review of an important emerging infection.
    Wallin MT; Kurtzke JF
    Neurology; 2004 Nov; 63(9):1559-64. PubMed ID: 15534236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism and other movement disorders in 23 cases of neurocysticercosis.
    Alarcón F; Cedeño Y; de Yébenes JG
    Parkinsonism Relat Disord; 2017 Sep; 42():47-53. PubMed ID: 28673613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the clinico radiological heterogeneity and the immune-inflammatory profiles in pediatric patients with neurocysticercosis from a tertiary referral centre.
    Kashyap B; Das S; Jain S; Agarwal A; Kaushik JS; Kaur IR
    J Trop Pediatr; 2012 Aug; 58(4):320-3. PubMed ID: 22123942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delirium diagnosis defined by cluster analysis of symptoms versus diagnosis by DSM and ICD criteria: diagnostic accuracy study.
    Sepulveda E; Franco JG; Trzepacz PT; Gaviria AM; Meagher DJ; Palma J; Viñuelas E; Grau I; Vilella E; de Pablo J
    BMC Psychiatry; 2016 May; 16():167. PubMed ID: 27229307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revised diagnostic criteria for neurocysticercosis.
    Del Brutto OH; Nash TE; White AC; Rajshekhar V; Wilkins PP; Singh G; Vasquez CM; Salgado P; Gilman RH; Garcia HH
    J Neurol Sci; 2017 Jan; 372():202-210. PubMed ID: 28017213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocysticercosis in the United States.
    Serpa JA; White AC
    Pathog Glob Health; 2012 Sep; 106(5):256-60. PubMed ID: 23265549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody specific to 43kDa excretory-secretory antigenic peptide of Taenia solium metacestode as a potential diagnostic marker in human neurocysticercosis.
    Sahu PS; Parija SC; Jayachandran S
    Acta Trop; 2010 Sep; 115(3):257-61. PubMed ID: 20399738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.